Got Trouble with Hair Loss? Buy Finasteride 1mg for Sale

Hair loss in men sometimes leads to baldness.  If you happen to see a bald man who seems to have lost their hair instead of having their head shaved bald, then they have male pattern baldness.  Male pattern baldness is actually a genetic condition that you inherit from your parents.  If you are a male and have older brothers or a dad who suffers from this hair loss condition, it is likely that you too will have inherited the condition and will soon suffer from it.  Normally, the condition of male pattern baldness can start as early as your late teens and will manifest by the time you reach your mid-twenties.

Although treatments are available for hair loss, they only manage to slow down the progression of the hair loss.  The true treatment for hair fall is called finasteride 1mg.  You can find finasteride 1mg for sale at your local pharmacy and you can also find finasteride 1mg for sale online.  The truth is that many buy their finasteride 1mg treatment online because they are able to get better savings by buying their hair fall meds on the internet.

In the past, there was really no effective treatment for hair loss aside from topical treatment that only attempt to slow down the progression of the genetic condition.  However, when Merck created the drug finasteride, everything about treating hair loss changed as the drug they actually made prevented the creation of the hormone that was responsible in the damaging and thinning of hair follicles which led to the thinning and dying of hair strands.  Although the discovery was accidental as finasteride was originally intended for another purpose, in the end, what they actually made was a very effective remedy for hair loss. Read more…

End of the line for the gravy train?

Pharma giant AstraZeneca will no longer fund doctors' travel to medical congresses, becoming the first leading drugmaker to renounce this common perk.

Announcing the step at an industry conference in Istanbul, that pharma "is a force for good. But if we're honest with ourselves ... we’re often seen as the bad guys."

He cited a recent in the U.S., which found that only 11% of Americans rated big pharma as trustworthy, when even banks had scored 20%. The same poll also found, though he didn't mention it, that pharma, along with oil, was the industry Americans most wanted to regulate more strictly.

His company had resolved to address the problem by "never doing anything that could be misinterpreted," said Mr Brennan. "We have decided that we will no longer pay for doctors to attend international scientific and medical congresses but will instead focus our educational efforts on local educational opportunities for healthcare professionals."

He added an interesting take on the doctor/pharm rep relationship from the other side of the fence: "I know from my own experience as a sales representative, you will encounter people who will ask for gifts, or other inducements. And they will threaten to take their business elsewhere, if you don’t acquiesce ... we have made it clear that our sales force have to say no."

It's likely that other pharma companies will follow AstraZeneca's lead. The industry acted in a fairly coordinated manner in abandoning free gits like mugs and mousepads in recent years. And the announcement carries extra significance because Brennan, the only leading pharm CEO to come from a background in sales rather than medicine or chemistry, is also president of the the International Federation of Pharmaceutical Manufacturers and Associations.

The drug industry has come under pressure recently over dealings abroad, particularly with employees of foreign public health services, including doctors. AstraZeneca and other British companies have had to contend with a new bribery act in the UK, while in the United States has been investigating big pharma under the Foreign Corrupt Practices Act (FCPA). Johnson & Johnson last month to settle British and American charges that it paid kickbacks to win business overseas. AstraZeneca itself is being investigated under FCPA for its dealings in China.